Drug Monographs
- Drug Type
- Biotech
- Brand Names
- Lantidra
Summary
Donislecel is an allogeneic pancreatic islets cellular therapy indicated for the treatment of type 1 diabetes
MedPath
Empowering clinical research with data-driven insights and AI-powered tools.
© 2025 MedPath, Inc. All rights reserved.